Newron Pharmaceuticals SpA – Strategy, SWOT and Corporate Finance Report
- Pages: 49
- Published: May 2018
- Report Code: MLPH82486FSA
Newron Pharmaceuticals SpA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Newron Pharmaceuticals SpA (Newron) is a research-based biopharmaceutical company which focuses on the discovery, development and commercialization of novel therapeutic drugs for the treatment of central nervous system disorders and pain. The company’s marketed product, Xadago (safinamide), is developed as an adjunctive therapy for any stage of Parkinson's disease. Newron’s other products in pipeline include ralfinamide for neuropathic pain; sarizotan for Rett syndrome; and Evenamide (NW-3509) for the treatment of schizophrenia. The company has development and commercialization collaborations with Zambon and Meiji Seika Pharma Co., Ltd. It operates along with its subsidiaries in the UK, Sweden, Switzerland and the US. Newron is headquartered in Bresso, Milan, Italy.
Scope
Detailed information on Newron Pharmaceuticals SpA required for business and competitor intelligence needs
A study of the major internal and external factors affecting Newron Pharmaceuticals SpA in the form of a SWOT analysis
An in-depth view of the business model of Newron Pharmaceuticals SpA including a breakdown and examination of key business segments
News about Newron Pharmaceuticals SpA, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Newron Pharmaceuticals SpA and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Newron Pharmaceuticals SpA as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Newron Pharmaceuticals SpAs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Ablynx NV
Biotie Therapies Corp
Pharming Group NV
Santhera Pharmaceuticals Holding AG
Silence Therapeutics Plc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.